Home > Products > CD28 & CD3 > Recombinant Human Anti-CD28 x Human Anti-CD3 Bispecific Antibody (IgG(L)-scFv)

Recombinant Human Anti-CD28 x Human Anti-CD3 Bispecific Antibody (IgG(L)-scFv)  (IGLFV-H230)

Recombinant Anti-CD28 x Anti-CD3 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD28 antibody are fused to the C terminus of an anti-CD3 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can improve T-cell activation. It is designed for the research of Tumors therapy.

Specifications

Targets
CD28 & CD3
Type
Appended IgGs
Species Reactivity
Human
Target 1
CD28
Host Animal 1
Human
Target 2
CD3
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Tumors

Targets

Target 1
CD28
Gene ID
UniProt ID
Alternative Names
CD28; CD28 molecule; Cluster of Differentiation 28; Tp44; T-cell-specific surface glycoprotein CD28; CD28 antigen
Target 2
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD28 x Human Anti-CD3 Bispecific Antibody (IgG(L)-scFv) (IGLFV-H230). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD28 & CD3"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: